FDA Allows Florida to Import Prescription Drugs From Canada

For the first time, the U.S. Food and Drug Administration (FDA) has given the OK for a state to import prescription drugs from Canada, where the prices for many life-sustaining medications are far lower than in the United States. This approval allows Florida’s health agency to begin putting in place a drug importation process for some state health programs.

States began passing importation laws in 2019 to bring down the runaway prices of prescription drugs. The first law was passed in Colorado, and since then, similar measures have been enacted in Florida, Maine, New Hampshire, New Mexico, North Dakota, Texas and Vermont. Even though Congress passed a law in 2003 allowing foreign-drug importation, federal health officials never moved ahead on such plans, citing safety concerns. Florida sued the FDA over the delay in approving the Sunshine State’s importation plan, and a federal judge gave the agency until Jan. 5 to act on the state’s application.

AARP Membership— $12 for your first year when you sign up for Automatic Renewal

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.

Join Now

As part of its campaign to lower medication prices, AARP has supported state and federal efforts to help consumers save money on prescription drugs, including drug importation. 

“The FDA approval is evidence that efforts to allow states to safely import prescription drugs from Canada are moving forward,” says Leigh Purvis, AARP prescription drug policy principal. “This is part of what is a growing list of efforts to try and reduce prescription drug prices and costs for the people who need them.”

AARP also successfully fought for provisions in a 2022 federal law, including Medicare negotiation of some medications for the first time, a $35 monthly copay cap on insulin, and rebates to Medicare for drug price increases that exceed the rate of inflation. This year, people with Medicare drug coverage will no longer have to pay any out-of-pocket costs after they qualify for catastrophic coverage. In 2025, a $2,000 out-of-pocket cap on Medicare-covered drugs will take effect under the law. 

AARP’s support for drug importation is rooted in the “common knowledge that Americans pay significantly higher prices for the same prescription drugs that other countries have,” Purvis says. “Being able to take advantage of the lower prices that are available in other countries is something that’s been very appealing for a long time.”